Skip to main content
SpringerLink
Log in

Vildagliptin

A Viewpoint by Michelle V. Gordon and Anna C. Calkin

  • Adis Drug Profiles
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  1. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000 Aug 12; 321(7258): 405–12

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diabetes Complications Laboratory, Baker Heart Research Institute, Melbourne, Victoria, Australia

    Michelle V. Gordon & Anna C. Calkin

Authors
  1. Michelle V. Gordon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna C. Calkin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gordon, M.V., Calkin, A.C. Vildagliptin. Drugs 66, 2002 (2006). https://doi.org/10.2165/00003495-200666150-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200666150-00009

Search

Navigation